Viewing Study NCT03339102


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-03-09 @ 4:43 AM
Study NCT ID: NCT03339102
Status: COMPLETED
Last Update Posted: 2021-07-19
First Post: 2017-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Post-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis Patients
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module